Skip to content

    Perceiv AI Joins Johnson & Johnson Innovation–JLABS Global Network to Accelerate Precision Medicine Platform Development 

    Perceiv AI, an AI-driven precision medicine company, today announced that it has joined Johnson & Johnson Innovation–JLABS, a premier life science incubator program. Perceiv AI will gain access to a variety of resources, including mentorship, and programming to accelerate the development of ForesightTM its multimodal prognostic platform.

    Perceiv AI’s platform integrates longitudinal clinical data, biomarkers with imaging, fluid biomarkers, and genetics to forecast disease progression in age-related diseases like Alzheimer’s. By providing a window into individual patients’ disease progression, Perceiv AI aims to accelerate and de-risk the development of new therapies while enabling timelier diagnoses.